You are here

  • Home
  • Archive
  • Volume 27, Issue 4
  • Economic evaluation of direct oral anticoagulants (DOACs) versus vitamin K antagonists (VKAs) for stroke prevention in patients with atrial fibrillation: a systematic review and meta-analysis

Article info

Article menu
Evidence synthesis
Economic evaluation of direct oral anticoagulants (DOACs) versus vitamin K antagonists (VKAs) for stroke prevention in patients with atrial fibrillation: a systematic review and meta-analysis

Authors

  • Rini Noviyani Mahidol University Health Technology Assessment (MUHTA) Graduate Program, Mahidol University, Bangkok, Thailand Department of Pharmacy, Faculty of Mathematics and Natural Sciences, Udayana University, Bali, Indonesia PubMed articlesGoogle scholar articles
  • Sitaporn Youngkong Mahidol University Health Technology Assessment (MUHTA) Graduate Program, Mahidol University, Bangkok, Thailand Social and Administrative Pharmacy Division, Department of Pharmacy, Faculty of Pharmacy, Mahidol University, Bangkok, Thailand PubMed articlesGoogle scholar articles
  • Surakit Nathisuwan Clinical Pharmacy Division, Department of Pharmacy, Faculty of Pharmacy, Mahidol University, Bangkok, Thailand PubMed articlesGoogle scholar articles
  • Bhavani Shankara Bagepally ICMR-National Institute of Epidemiology, Chennai, India PubMed articlesGoogle scholar articles
  • Usa Chaikledkaew Mahidol University Health Technology Assessment (MUHTA) Graduate Program, Mahidol University, Bangkok, Thailand Social and Administrative Pharmacy Division, Department of Pharmacy, Faculty of Pharmacy, Mahidol University, Bangkok, Thailand PubMed articlesGoogle scholar articles
  • Nathorn Chaiyakunapruk Department of Pharmacotherapy, College of Pharmacy, University of Utah, Salt Lake City, Utah, USA PubMed articlesGoogle scholar articles
  • Gareth McKay Centre for Public Health, School of Medicine, Dentistry and Biomedical Sciences, Queen's University, Belfast, UK PubMed articlesGoogle scholar articles
  • Piyamitr Sritara Division of Cardiology, Department of Medicine, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand PubMed articlesGoogle scholar articles
  • John Attia School of Medicine and Public Health, Faculty of Health and Medicine, University of Newcastle, New South Wales, New South Wales, Australia PubMed articlesGoogle scholar articles
  • Ammarin Thakkinstian Mahidol University Health Technology Assessment (MUHTA) Graduate Program, Mahidol University, Bangkok, Thailand Department of Clinical Epidemiology and Biostatistics, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Sitaporn Youngkong, Mahidol University Faculty of Pharmacy, Bangkok, Thailand; sitaporn.you{at}mahidol.edu
View Full Text

Citation

Noviyani R, Youngkong S, Nathisuwan S, et al
Economic evaluation of direct oral anticoagulants (DOACs) versus vitamin K antagonists (VKAs) for stroke prevention in patients with atrial fibrillation: a systematic review and meta-analysis
BMJ Evidence-Based Medicine 2022;27:215-223.

Publication history

  • Accepted September 14, 2021
  • First published October 11, 2021.
Online issue publication 
October 18, 2023

Article Versions

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.